Brief Intervention for Prescription Drug Misuse in General Hospital
MIMIK
Brief Intervention for Regular Prescription Drug Use and Prescription Drug Use Disorders in General Hospital
1 other identifier
interventional
126
0 countries
N/A
Brief Summary
In a randomized controlled trial, patients recruited in a general hospital and fulfilling criteria for regular consumption (more than 60 days within the last three months), dependence or abuse of prescription drugs will be randomly allocated to two conditions:(1) Intervention group consisting of two counselling sessions based on Motivational Interviewing plus a personalized feedback, (2) Control group receiving a booklet on health behavior. Outcome assessment will be conducted after 12 months. The hypothesis is that counseling leads to greater reduction in consumption of prescription drugs (including discontinuation) and elevated readiness to change at follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2005
Typical duration for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 9, 2007
CompletedFirst Posted
Study publicly available on registry
August 10, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2009
CompletedApril 2, 2014
April 1, 2014
2.8 years
August 9, 2007
April 1, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Discontinuation of consumption of prescription drugs
one year
Reduction of consumption of prescription drugs
one year
Utilization of formal help
one year
Secondary Outcomes (1)
Readiness to change consumption of prescription drugs
one year
Study Arms (2)
C
NO INTERVENTIONControl group receiving a booklet on health behavior
MI
EXPERIMENTALCounselling based on Motivational Interviewing plus individualized feedback
Interventions
Two sessions of Motivational Interviewing (after baseline assessment and 4 weeks later) plus one individualized feedback based on the Transtheoretical Model of Behavior Change (8 weeks after baseline assessment)
Eligibility Criteria
You may qualify if:
- Prescription drug abuse
- Prescription drug dependence
- Regular prescription drug consumption (\>60 times/last three months)
You may not qualify if:
- Current treatment for substance abuse problems
- Terminal illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Luebecklead
- Federal Ministry of Health, Germanycollaborator
Related Publications (1)
Zahradnik A, Otto C, Crackau B, Lohrmann I, Bischof G, John U, Rumpf HJ. Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients. Addiction. 2009 Jan;104(1):109-17. doi: 10.1111/j.1360-0443.2008.02421.x.
PMID: 19133895DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hans-Juergen Rumpf, Ph.D.
University of Luebeck
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PD Dr. Hans-Jürgen Rumpf
Study Record Dates
First Submitted
August 9, 2007
First Posted
August 10, 2007
Study Start
November 1, 2005
Primary Completion
August 1, 2008
Study Completion
February 1, 2009
Last Updated
April 2, 2014
Record last verified: 2014-04